IP Library Granted Patent US 7,824,676
Granted Patent B2
US 7,824,676 · App. 11/522,043 · Granted Nov 2, 2010

Exocrine gland tight junction-constituting protein jeap family

Assignee: Eisai R&D Management Co., Ltd.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,824,676
App. No.
11/522,043
Granted
Nov 2, 2010
Kind
B2
Abstract

A mouse cDNA library from gene fragments encoding proteins localizing at cell-cell junctions was screened by a technique visualizing localization of a protein to identify a junction-enriched and -associated protein, JEAP. GenBank homology search was performed based on the sequence. Based on the obtained sequence, a mouse cDNA library was screened to identify JEAP-2. By using prepared antibodies against these proteins, it was revealed that these proteins express specifically at tight junctions, in particular, tight junctions in exocrine glands.

Claims (18)

1. An isolated antibody or functional fragment thereof that binds to a protein having an amino acid sequence shown in SEQ ID NO:4.

2. The antibody or functional fragment thereof of claim 1 , wherein the antibody is a monoclonal antibody.

3. The antibody or functional fragment thereof of claim 1 , wherein the antibody is a polyclonal antibody.

4. The antibody or functional fragment thereof of claim 1 , wherein the antibody is a chimeric antibody.

5. The antibody or functional fragment thereof of claim 1 , wherein the antibody is a humanized antibody.

6. The antibody or functional fragment thereof of claim 1 , wherein the functional fragment is an Fab or Fab′ antibody fragment.

7. The antibody or functional fragment thereof of claim 1 , wherein the antibody or functional fragment thereof is labeled.

8. The antibody or functional fragment thereof of claim 7 , wherein the antibody or functional fragment thereof is labeled with a fluorescent tag.

9. The antibody or functional fragment thereof of claim 7 , wherein the antibody or functional fragment thereof is labeled with an enzymatic tag.

10. An isolated antibody or functional fragment thereof that binds to the protein of the sequence shown in SEQ ID NO:4.

11. The antibody or functional fragment thereof of claim 10 , wherein the antibody is a monoclonal antibody.

12. The antibody or functional fragment thereof of claim 10 , wherein the antibody is a polyclonal antibody.

13. The antibody or functional fragment thereof of claim 10 , wherein the antibody is a chimeric antibody.

14. The antibody or functional fragment thereof of claim 10 , wherein the antibody is a humanized antibody.

15. The antibody or functional fragment thereof of claim 10 , wherein the functional fragment is an Fab or Fab′ antibody fragment.

16. The antibody or functional fragment thereof of claim 10 , wherein the antibody or functional fragment thereof is labeled.

17. The antibody or functional fragment thereof of claim 16 , wherein the antibody or functional fragment thereof is labeled with a fluorescent tag.

18. The antibody or functional fragment thereof of claim 16 , wherein the antibody or functional fragment thereof is labeled with an enzymatic tag.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 2, 2007
From: EISAI CO., LTD.
To: EISAI R&D MANAGEMENT CO., LTD.
Reel/Frame 019235/0487 →
Continuity (1)
Related Publication 20080119641A1 · May 22, 2008